When.com Web Search

  1. Ads

    related to: non hodgkin's lymphoma diet plan

Search results

  1. Results From The WOW.Com Content Network
  2. Non-Hodgkin lymphoma - Wikipedia

    en.wikipedia.org/wiki/Non-Hodgkin_lymphoma

    Non-Hodgkin lymphoma (NHL), also known as non-Hodgkin's lymphoma, is a group of blood cancers that includes all types of lymphomas except Hodgkin lymphomas. [1] Symptoms include enlarged lymph nodes, fever, night sweats, weight loss, and tiredness. [1] Other symptoms may include bone pain, chest pain, or itchiness. [1]

  3. CHOP (chemotherapy) - Wikipedia

    en.wikipedia.org/wiki/CHOP_(chemotherapy)

    This regimen can also be combined with the monoclonal antibody rituximab if the lymphoma is of B cell origin; this combination is called R-CHOP. In 2002, a randomized controlled trial showed a higher complete response rate for R-CHOP vs CHOP in elderly patients with Diffuse Large-B-Cell Lymphoma (76% vs 63%). [ 4 ]

  4. sorted under lymphomas according to current WHO classification; called small lymphocytic lymphoma (SLL) when leukemic cells are absent. 10.2% Chronic myelogenous leukemia (CML) 3.7% Acute monocytic leukemia (AMoL) 0.7% Other leukemias 3.1% Lymphomas — 55.6% Hodgkin's lymphomas (all four subtypes) 7.0% Non-Hodgkin's lymphomas (all subtypes) 48 ...

  5. What is non-Hodgkin lymphoma? - AOL

    www.aol.com/lifestyle/full-house-star-david...

    Non-Hodgkin lymphoma (sometimes simply called NHL) is a form of blood cancer that strikes the white blood cells of the infection-fighting lymphatic system.

  6. Mantle cell lymphoma - Wikipedia

    en.wikipedia.org/wiki/Mantle_cell_lymphoma

    Mantle cell lymphoma (MCL) is a type of non-Hodgkin's lymphoma, comprising about 6% of cases. [ 1 ] [ 2 ] It is named for the mantle zone of the lymph nodes where it develops. [ 3 ] [ 4 ] The term 'mantle cell lymphoma' was first adopted by Raffeld and Jaffe in 1991.

  7. Chemotherapy - Wikipedia

    en.wikipedia.org/wiki/Chemotherapy

    As chemotherapy affects cell division, tumors with high growth rates (such as acute myelogenous leukemia and the aggressive lymphomas, including Hodgkin's disease) are more sensitive to chemotherapy, as a larger proportion of the targeted cells are undergoing cell division at any time.